comparison of anterior decompression and interbody fusion with and without orion locking plate for cervical spondylotic myelopathy

1、

treatment of cervical spondylotic myelopathy with bryan cervical disc prosthesis replacement in 8 cases

Bryan人工颈椎间盘置换治疗脊髓型颈椎病8例

互联网摘选

2、

objective and precise reliability of joa scoring system for cervical spondylotic myelopathy

脊髓型颈椎病JOA指数的客观和精确信度调查

互联网摘选

3、

objective: to investigate the relationship between mri changes and clinical curative effect after anterior decompression and fusion ( adf) of cervical spondylotic myelopathy ( csm).

目的：研究脊髓型颈椎病前路减压及融合术后的MRI表现与临床意义，评价术后MRI表现及其与术后疗效的关系。

互联网摘选

4、

clinical research on diffusion weighted imaging in cervical spondylotic myelopathy

磁共振DWI成像技术在脊髓型颈椎病的临床研究

互联网摘选

5、

report of treatment in 36 patients with cervical spondylotic myelopathy operated by anterior approach and cage implanted

前路减压加Cage椎间融合器植入治疗脊髓型颈椎病36例临床观察

互联网摘选

6、

objective to explore the relationship between the mri changes and the clinical prognosis of patients with cervical spondylotic myelopathy.

目的探讨脊髓型颈椎病的MRI改变与患者临床预后的相关性。

互联网摘选

7、

conclusion: mri is important for predicting the prognosis of the cervical spondylosis with myelopathy.

结论：MRI对脊髓型颈椎病预后判断有重要意义。

互联网摘选

8、

the value of spinal canal volume with cervical spondylotic myelopathy measured quantitatively on three-dimensional mri

MRI立体定量测量椎管在脊髓型颈椎病发病中的意义

互联网摘选

9、

imaging analysis of cord compression factors in csm by using mri motion scan technique

MRI运动扫描分析脊髓型颈椎病的脊髓致压因素

互联网摘选

10、

method: from december 2003 to may 2005,67 cases of csm patients were treated surgically by cervical arthroplasty using bryan disc prosthesis.

方法：2003年12月～2005年5月应用Bryan颈椎间盘假体置换术治疗脊髓型颈椎病患者67例，其中28例合并有神经根型表现。

互联网摘选

11、

conclusion: mri, based on signal changes, can be helpful to reflect the conditions of graft bone fusion and lay radiological foundation to evaluate adf of csm.

结论：MRI可根据信号变化反映前路植骨融合状况，并通过术后MRI不同表现为评价脊髓型颈椎病前路术后的功能变化提供了影像学基础。

互联网摘选

12、

Karnofsky score, blood routine, hemorrheologic state and the immune function including NK cell activity, T lymphocyte differentiation and the serum soluble interleukin-2 receptor ( SIL-2R) concentration before and after the treatment were observed.

观察治疗前后卡氏评分、外周血常规和血液流变学的变化，并观察自然杀伤（NK）细胞、T淋巴细胞亚群、可溶性白细胞介素2受体（SIL2R）等指标的变化。

互联网摘选

13、

Serum concentrations of albumin, prealbumin and transferrin, body weight, Karnofsky performance score ( KPS) were examined regularly.

定期检查血清白蛋白、前白蛋白和转铁蛋白、体重、体质指数和进行卡氏行为状态评分（KPS）。

互联网摘选

14、

Cox regression analysis indicated that therapy, gender, disease course, erythrocyte sedimentation, KPS score, tumor size, and patient's weight were independent prognostic factors of stage ⅲ-ⅳ NSCLC.

COX回归模型分析，治疗因素、性别、病程、血沉、卡氏（KPS）评分、瘤体大小、体重是独立的预后因素。

互联网摘选

15、

Moreover, the improvement of clinical symptoms, Karnofsky scoring, body weight and peripheral blood picture in the treated group was superior to that in the control group.

在改善临床症状、卡氏评分、增加体重，以及对治疗后外周血象变化的改善方面，A组患者比B组更明显。

互联网摘选

16、

The information of patients' age, gender, Karnofsky score, tumour size, tumour pathology, tumour location, prescription radiation dose and survival time were collected.

收集患者的年龄、性别、术前癫痫情况、卡氏评分、肿瘤大小、肿瘤生长部位、肿瘤病理类型、放疗剂量、是否同步放化疗、是否复发及生存时间等信息。

互联网摘选

17、

Karnofsky physical status ( KPS)≥ 60 in therapy group was higher than control group after treatment ( P < 0.01).

卡氏体力评分≥60分治疗组则明显高于对照组（P<0.01）。

互联网摘选

18、

Results There were 65 cases ( 65%) with depression according to SDS. The incidence of depression related to the grade of pain. After treatment with TCM the SDS became significantly lower ( P < 0.05).

结果癌痛患者伴发抑郁的发病率为65%，其影响因素主要为疼痛程度、卡氏评分、疼痛时间、性别等，中药治疗后SDS评分较对照组明显下降（P<0.05）。

互联网摘选

19、

Karnofsky ≥ 70. No chemotherapy contraindications Checked before chemotherapy.

卡氏评分≥70分，化疗前经检查无化疗禁忌症。

互联网摘选

20、

The main observation indexes were tumor size, Karnofsky scores, body weight, adverse reaction, etc.

治疗期3个月，主要观察指标为瘤体大小、卡氏评分、体重、不良反应等。

互联网摘选